Kuros Strengthens Its Leadership Team with Adam Wollowick

As CMO, Adam will oversee Kuros’s global medical and clinical affairs, strengthening the generation of clinical evidence, advancing scientific strategy, and deepening physician engagement. He brings a unique perspective to the industry, with extensive experience in orthopedic spine surgery, clinical research, and strategic business leadership. His career includes academic medicine and over a decade of senior leadership in the medical device industry.

Chris Fair, Chief Executive Officer of Kuros Biosciences, said: “We are delighted to welcome Dr. Adam Wollowick as CMO. His rare combination of clinical, scientific, and business expertise makes him exceptionally well-positioned to advance our clinical and medical affairs capabilities as we continue to expand our portfolio and drive growth.”

And here’s a fun fact: Before attending medical school and earning his MBA from Yale, Adam studied art history at Dartmouth.